POINT OF CARE DIAGNOSTICS FOR URINARY TRACT INFECTION
尿路感染的护理点诊断
基本信息
- 批准号:8394577
- 负责人:
- 金额:$ 29.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-07-02 至 2014-12-31
- 项目状态:已结题
- 来源:
- 关键词:Accident and Emergency departmentAgeAntimicrobial susceptibilityBacteriaBacterial InfectionsBiological AssayBuffersCaringChildClinicalCoagulaseColony-forming unitsCommunicable DiseasesDetectionDevelopmentDevicesDiagnosisDiagnosticDiagnostic testsDiseaseDoctor of PhilosophyEnterococcusEscherichia coliExhibitsFemaleGenus staphylococcusGoalsGoldGrowthHourHypersensitivityIndividualInfectionKineticsKlebsiella pneumonia bacteriumLabelLaboratoriesLifeMarketingMedicineMicrofluidicsMolecularNucleic Acid ProbesOrganismPatientsPatternPeptide Nucleic AcidsProteus mirabilisPseudomonas aeruginosaPumpReproducibilityResourcesRibosomal RNARunningSamplingSepsisSexually Transmitted DiseasesSmall Business Innovation Research GrantSpecificitySpecimenSystemTechnologyTestingTimeTimeLineUnited StatesUniversitiesUrinary tract infectionUrineUrologic DiseasesWashingtonassay developmentbasebody systemclinically significantcost effectivedesignelectric impedanceinnovationmalemetermicroorganismnucleic acid detectionpathogenpoint-of-care diagnosticsprofessorsample collectionsensor
项目摘要
DESCRIPTION (provided by applicant): Urinary tract infection (UTI) is an extremely common condition that occurs in both males and females of all ages and in children. UTI is the most common urological disease in the United States and the second most common bacterial infection of any organ system. Urinary tract infection (UTI) is defined by the presence of a growth of more than 105 colony forming units (CFU) of bacteria per mL of urine for asymptomatic individual and much lower for symptomatic individuals (~103 CFU/mL). The "gold standard" for UTI diagnosis is microbiological urine culture. However, a major drawback of urine culture systems is the time lag of approximately 2 days between specimen collection and pathogen identification. Currently available rapid diagnostic tests exhibit poor sensitivities and/r specificities for UTI. A rapid, sensitive, easy to use POC based molecular approach for accurate and reliable detection and identification of clinically significant concentrations of bacterial pathogens in clinical urine specimens would be of considerable benefit. The overall goal of this SBIR project is to develop a cost effective, sensitive, easy to use device for diagnosing Urinary Tract Infection (UTI) at the Point Of Care (POC). The application of our proposed technology will be directed towards the development of a sensor array specifically for the microorganisms most commonly associated with UTI including E. coli, and coagulase negative Staphylococcus. During PHASE II we will expand the menu to include for the detection of other organisms including Klebsiella pneumoniae, Proteus mirabilis, Enterococcus sp., Pseudomonas aeruginosa.
PUBLIC HEALTH RELEVANCE: Urinary tract infection (UTI) is an extremely common condition that occurs in both males and females of all ages and in children. Currently available rapid diagnostic tests exhibit poor sensitivities and/or specificities for UTI. A rapid, sensitive, easy o use POC based molecular approach for accurate and reliable detection and identification of clinically significant concentrations of bacterial pathogens in clinical urine specimens would be of considerable benefit.
描述(由申请人提供):尿路感染(UTI)是一种极其常见的疾病,发生在所有年龄段的男性和女性以及儿童中。UTI是美国最常见的泌尿系统疾病,也是任何器官系统中第二常见的细菌感染。尿路感染(UTI)定义为无症状个体每mL尿液中细菌生长超过105个菌落形成单位(CFU),而有症状个体的细菌生长更低(约103 CFU/mL)。尿路感染诊断的“金标准”是尿微生物培养。然而,尿培养系统的一个主要缺点是样本采集和病原体鉴定之间约2天的时间滞后。目前可用的快速诊断测试对UTI表现出差的灵敏度和/或特异性。一种快速、灵敏、易于使用的基于POC的分子方法,用于准确和可靠地检测和鉴定临床尿液样本中临床显著浓度的细菌病原体,将是相当有益的。该SBIR项目的总体目标是开发一种具有成本效益、灵敏、易于使用的设备,用于在护理点(POC)诊断尿路感染(UTI)。我们所提出的技术的应用将针对于开发一种传感器阵列,该传感器阵列专门用于最常见的与UTI相关的微生物,包括大肠杆菌。大肠杆菌和凝固酶阴性葡萄球菌。在第二阶段,我们将扩大菜单,包括检测其他微生物,包括肺炎克雷伯菌,奇异变形杆菌,肠球菌,绿脓杆菌。
公共卫生相关性:尿路感染(UTI)是一种非常常见的疾病,发生在所有年龄段的男性和女性以及儿童中。目前可用的快速诊断测试对UTI表现出较差的灵敏度和/或特异性。一种快速、灵敏、易于使用的基于POC的分子方法,用于准确和可靠地检测和鉴定临床尿液样本中临床显著浓度的细菌病原体,将是相当有益的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KUMAR SUBRAMANIAN其他文献
KUMAR SUBRAMANIAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KUMAR SUBRAMANIAN', 18)}}的其他基金
Low cost, automated smartphone based assay for semen analysis
用于精液分析的低成本、基于智能手机的自动化检测
- 批准号:
10028296 - 财政年份:2020
- 资助金额:
$ 29.49万 - 项目类别:
Multiplexed Point Of Care Nucleic Acid Assay for STI
STI 多重护理点核酸检测
- 批准号:
9074908 - 财政年份:2016
- 资助金额:
$ 29.49万 - 项目类别:
IGF::OT::IGFTitle: Multiplexed Biosensor for Detecting Low Abundance Cancer-rel
IGF::OT::IGFTTitle:用于检测低丰度癌症相关的多重生物传感器
- 批准号:
8761949 - 财政年份:2013
- 资助金额:
$ 29.49万 - 项目类别:
RAPID AND SENSITIVE IDENTIFICATION OF HIV ANTIGEN AT THE POINT OF USE
在使用时快速、灵敏地鉴定 HIV 抗原
- 批准号:
8603499 - 财政年份:2013
- 资助金额:
$ 29.49万 - 项目类别:
Improved methodologies to measure novel alcohol biomarkers in whole blood
改进的方法来测量全血中新型酒精生物标志物
- 批准号:
8183977 - 财政年份:2012
- 资助金额:
$ 29.49万 - 项目类别:
High throughput Point-of-Care assays for diabetes auto-antibody detection
用于糖尿病自身抗体检测的高通量即时检测
- 批准号:
8402736 - 财政年份:2012
- 资助金额:
$ 29.49万 - 项目类别:
Multiplexed Biomarkers for staging Alzheimer???s Disease
用于分期阿尔茨海默病的多重生物标志物
- 批准号:
8371247 - 财政年份:2012
- 资助金额:
$ 29.49万 - 项目类别:
High throughput Point-of-Care assays for diabetes auto-antibody detection
用于糖尿病自身抗体检测的高通量即时检测
- 批准号:
8546380 - 财政年份:2012
- 资助金额:
$ 29.49万 - 项目类别:
MULTIPLEXED BIOSENSOR FOR DETECTING LOW ABUNDANCE CANCER
用于检测低丰度癌症的多重生物传感器
- 批准号:
8356444 - 财政年份:2011
- 资助金额:
$ 29.49万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
Fellowship
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
Continuing Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
Standard Grant
The economics of (mis)information in the age of social media
社交媒体时代(错误)信息的经济学
- 批准号:
DP240103257 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
Discovery Projects
How age & sex impact the transcriptional control of mammalian muscle growth
你多大
- 批准号:
DP240100408 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
Discovery Projects
Supporting teachers and teaching in the age of Artificial Intelligence
支持人工智能时代的教师和教学
- 批准号:
DP240100111 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
Discovery Projects
Enhancing Wahkohtowin (Kinship beyond the immediate family) Community-based models of care to reach and support Indigenous and racialized women of reproductive age and pregnant women in Canada for the prevention of congenital syphilis
加强 Wahkohtowin(直系亲属以外的亲属关系)以社区为基础的护理模式,以接触和支持加拿大的土著和种族育龄妇女以及孕妇,预防先天梅毒
- 批准号:
502786 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
Directed Grant